Mergers and Acquisitions

* On June 24, 2013, Transgene, a biopharmaceutical company that develops immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, has announced that its affiliate Platine Pharma Services SAS (Platine), specialized in providing immune-monitoring services (quantitative measurement of immune response to products that stimulate the immune system) is acquiring immuno-monitoring activities of Indicia Biotechnology. The acquired activities are the development of immunoassays as well as the proprietary platform Immunoline™ dedicated to the immunogenicity risk assessment of biologicals.

This transaction will be a contribution in kind whereby Indicia Biotechnology will dispose of the aforementioned assets to Platine in exchange for new shares in the capital of the latter. It will be submitted to the shareholders’ approval of both companies on July 31, 2013.